• <table id="gigg0"></table>
  • west china medical publishers
    Keyword
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Keyword "慢性阻塞性肺疾病" 470 results
    • Renew the concept of chronic obstructive pulmonary disease

      《Lancetgt;雜志2007年9月9589號的封面以“目前在中國人口中估計有超過190萬死于從不吸煙的被動吸煙者”為警示,并組織了一期慢性阻塞性肺疾病(COPD)專輯,涉及內容廣泛且頗具新意。

      Release date:2016-08-30 11:37 Export PDF Favorites Scan
    • 氦氧混合氣Heliox 在慢性阻塞性肺疾病治療中的應用進展

      Heliox 是氦氣和氧氣相混合后制成的一種低密度混合氣體, 通常應用于深水潛水作業防止肺減壓傷的發生。由于Heliox 的特殊物理特性, 吸入Heliox 后可降低氣體在支氣管樹中的流速阻力, 從而降低氣道阻力, 因此為臨床工作者所重視, 也被逐步應用到了臨床聲帶障礙、喉炎、上氣道阻塞、支氣管炎及支氣管肺發育異常等疾病, 以及重癥監護室針對重癥哮喘、慢性阻塞性肺疾病/ 慢性阻塞性肺疾病急性加重( COPD/AECOPD) 患者的治療中。本文主要就Heliox 的物理學特性及作用原理, 以及在COPD/AECOPD 患者中的臨床應用作一綜述。

      Release date:2016-08-30 11:53 Export PDF Favorites Scan
    • Challenges in China :Prevention and Treatment of COPD

      隨著近年來對慢性阻塞性肺疾病( COPD) 的深入研究,人們逐漸揭示了其發病機制中的眾多關鍵環節,據此開發了新型的藥物和治療手段。大量國際多中心臨床研究已證明COPD 是一個可防可治的疾病,正確的治療能夠改善患者的癥狀,提高生活質量,乃至延緩疾病的進程。為更好地防治COPD,全球學者共同推出了《慢性阻塞性肺疾病全球倡議 ( GOLD) 》以指導廣大醫師規范、合理地診斷、治療和預防COPD。然而, 在我國由于多方面的原因,COPD 的防治工作面臨如下的難題。

      Release date: Export PDF Favorites Scan
    • 呼吸肌功能鍛煉對慢性阻塞性肺疾病康復期患者肺功能和生存質量的影晌

      目的:探討呼吸肌功能鍛煉對慢性阻塞性肺疾病(COPD)康復期患者肺功能和生存質量的影響。方法:采用自身前后對照的方法,對66例COPD康復期的患者進行健康評估,教會縮唇呼吸、腹式呼吸、呼吸操等呼吸肌功能鍛煉方法,鍛煉6~12個月, 平均(8.47土4.68)個月。測定患者肺功能,并用生存質量表(SF-36)進行生存測評。結果:呼吸肌鍛煉后肺功能指標均有明顯改善(均Plt;0.05),生存質量各維度評分與鍛煉前比較,差異有統計學意義(均Plt;0.05)。結論:呼吸肌功能鍛煉有改善肺功能和生存質量的作用。

      Release date:2016-09-08 10:02 Export PDF Favorites Scan
    • Comparison of cardiovascular risk factors in patients with chronic obstructive pulmonary disease of different severities

      Objectives To analyze the risk factors for cardiovascular disease (CVD) in patients with chronic obstructive pulmonary disease (COPD) of different severities. Methods The study included 50 patients with mild-to-moderate COPD and 50 with severe-to-very severe COPD admitted between January 2014 and January 2016. Comorbidities were recorded on the basis of data obtained from medical charts and clinical evaluations. The Charlson comorbidity index was calculated, and the Hospital Anxiety and Depression Scale (HADS) score was determined in each subject. Results There were more prevalences of smoking, depression and dyslipidemia in the patients with mild-to-moderate COPD than those with severe-to-very severe COPD (all P<0.001). The prevalences of high blood pressure, diabetes mellitus, alcoholism, and chronic heart failure were not different significantly between the two groups. The Charlson comorbidity index and HADS scores were not different between the two groups. Conclusions Comorbidities are fairly common in COPD regardless of its severity. Certain risk factors for CVD, as smoking, dyslipidemia, and depression, appear to be more prevalent in patients with mild-to-moderate COPD.

      Release date:2017-07-24 01:54 Export PDF Favorites Scan
    • Study on the correlation between EOS and clinical features and prognosis in patients with acute exacerbation of chronic obstructive pulmonary disease

      Objective The purpose of this study was to explore the correlation between peripheral blood eosinophil (EOS) count and smoking history, some inflammatory indicators, lung function, efficacy of ICS, risk of respiratory failure and chronic pulmonary heart disease, risk of acute exacerbation within 1 year, readmission rate and mortality in patients with acute exacerbation of COPD. Methods Retrospective analysis of the baseline clinical data of 816 patients with acute exacerbation of chronic obstructive pulmonary disease in the Department of Respiratory and Critical Care Medicine of the First Affiliated Hospital of Shihezi University from January 1,2019 to December 31,2021. The patients were divided into EOS ≥ 200 cells / μL (High Eosinophi, HE) group and EOS<200 cells / μL (low Eosinophi, LE) group according to whether the peripheral blood EOS was greater than 200 cells / μL at admission. Peripheral venous blood data (including blood eosinophil count, white blood cell count, lymphocyte percentage, neutrophil percentage), blood gas analysis value, lung function index and medication regimen of all patients were collected, and the efficacy of ICS was recorded. The patients were followed up for 1 year to observe the acute exacerbation and readmission rate, and the mortality rate was followed up for 1 year and 2 years. Results Neutrophil count, lymphocyte count and peak expiratory flow (PEF) in HE group were positively correlated with EOS value (P<0.05), and smoking was more likely to increase EOS value. HE group was more sensitive to ICS. The risk of acute exacerbation in HEA group was higher than that in LE group. ICS could reduce the rate of acute exacerbation in HE group. EOS value in LE group was inversely proportional to FEV1 / FVC and MMEF values (P<0.05). The risk of chronic pulmonary heart disease in LE group was higher than that in HE group. The 2-year mortality rate in HE group was higher than that in LE group. Conclusions Peripheral blood EOS count is correlated with some inflammatory indicators, acute exacerbation risk, and lung function. ICS can improve the clinical symptoms and prognosis of patients with higher EOS count.

      Release date:2025-08-25 05:39 Export PDF Favorites Scan
    • 不同運動策略對穩定期慢性阻塞性肺疾病患者的影響

      目的 比較不同運動策略對慢性阻塞性肺疾病(簡稱慢阻肺)患者的康復訓練效果。 方法 收集 2016 年 1 月至 2017 年 1 月在華北石油管理局總醫院呼吸內科門診隨訪的慢阻肺患者 86 例,隨機分為策略一組與策略二組,每組 43 例。在常規藥物治療及健康教育基礎上,策略一組采用功率自行車訓練,策略二組采用地面行走訓練。在訓練進行至 12 周及 24 周時分別比較兩組訓練前后第 1 秒用力呼氣容積占預計值百分比(FEV1%pred)、第 1 秒用力呼吸容積占用力肺活量百分比(FEV1/FVC)、最大攝氧量(VO2max)、6 分鐘步行距離(6MWD)、BODE 指數、慢性阻塞性肺疾病評估測試(CAT)評分、改良英國醫學研究委員會呼吸困難量表、Borg 呼吸困難評分是否有差異,并進行兩組間比較。 結果 在訓練進行至 12 周時策略一組、策略二組患者訓練后各組指標均有改善,其中除肺功能指標外差異均有統計學意義(均 P<0.05)。同時兩組患者康復運動后指標進行比較,策略一組各組數據均數較策略二組有好轉,其中 VO2max、6MWD、BODE 指數差異有統計學意義(均 P<0.05)。在訓練進行至 24 周時策略一組、策略二組患者較 12 周時各組指標均有改善,其中 6MWD、BODE 指數、Borg 評分、CAT 評分結果差異有統計學意義(均P<0.05)。同時兩組患者康復運動后指標進行比較,策略一組各組數據均數較策略二組有好轉趨勢,但差異均無統計學意義(均P>0.05)。 結論 在慢阻肺患者康復訓練中,功率自行車訓練在短期內具有一定的優勢,但堅持訓練后兩種訓練方式基本無明顯差異。

      Release date:2018-07-23 03:28 Export PDF Favorites Scan
    • Prognostic Factors of Hospitalized Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

      Objective To investigate the prognostic factors related to in-hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease ( AECOPD) . Methods A prospective cohort study was carried out in AECOPD patients admitted in three district general hospitals of Jiangyou city, Sichuan province from February 2007 to February 2008. The clinical and epidemiological data at admission and all-cause death in hospital were recorded. The in-hospital mortality rate and potential determinants of mortality of AECOPD were analyzed using Logistic regression method. Results 257 AECOPD inpatients with AECOPD were recruited into the cohort study. The in-hospital mortality rate was 5.84% (15/257) . Univariate analysis showed in-hospital mortality was significantly associated with age, FEV1% pred, arterial oxygen tension ( PaO2 ) , arterial oxygen saturation ( SaO2 ) , pH, and Charlson’s complication index. Multivariate logistic regression model showed that lower arterial oxygen tension ( OR 4.775;95%CI 1.545 ~14.757; P =0.007) and higher Charlson’s complication index ( OR 4. 608; 95% CI 1. 330 ~15. 966; P =0. 016) were significantly associated with in-hospital mortality after adjustment by age. Conclusion For in-patients with AECOPD, PaO2 and Charlson’s complication index are independent risk factors associated with in-hospital mortality.

      Release date:2016-09-13 03:46 Export PDF Favorites Scan
    • 慢性阻塞性肺疾病與自身免疫

      慢性阻塞性肺疾病( COPD) 是目前全球第4 大死因, 且患病率仍不斷上升[ 1] , 臨床治療手段也僅能緩解癥狀而不能逆轉病程[ 2] 。目前公認的發病機制包括炎癥、氧化/ 抗氧化和蛋白酶/ 抗蛋白酶等, 由于對COPD 的發病機制缺乏更深入的了解和更新的研究, 新的治療手段極其有限[ 3 ] 。近年來越來越多的研究顯示自身免疫可能是COPD 發病的關鍵機制。......

      Release date:2016-09-13 04:07 Export PDF Favorites Scan
    • 經鼻高流量氧療治療慢性阻塞性肺疾病急性加重合并Ⅱ型呼吸衰竭的臨床療效觀察

      目的 探討經鼻高流量氧療(HFNC)治療慢性阻塞性肺疾病(簡稱慢阻肺)急性加重合并Ⅱ型呼吸衰竭的臨床療效。方法 選取2017年1月至2019年3月昆山市第三人民醫院收治的慢阻肺急性加重合并Ⅱ型呼吸衰竭患者的病例資料進行回顧性分析,共108例。在標準治療的基礎上根據給氧方式分成HFNC組(33例)、無創正壓機械通氣(NPPV)組(35例)和低流量氧療組(40例)。觀察三組患者治療前后動脈血氣指標、生命體征指標和不良反應,比較三組治療模式臨床轉歸的差異。結果 HFNC組和NPPV組治療后的血氣分析(PaO2、PaCO2及pH)、心率、氣管插管率、生活質量評價等指標上顯著優于低流量氧療組,HFNC組和NPPV組平均住院時間均短于低流量氧療組,HFNC組治療后的心率、呼吸頻率、腹腔脹氣、顏面部壓傷、鼻黏膜干燥和出血等顯著優于NPPV組及低流量氧療組,差異有顯著統計學意義(P<0.05)。結論 對于治療慢阻肺急性加重合并Ⅱ型呼吸衰竭的患者,HFNC和NPPV均有較好的臨床效果。HFNC具有不良反應少、患者耐受性好等特點,在慢阻肺急性加重合并Ⅱ型呼吸衰竭治療中值得推廣應用。

      Release date:2022-02-19 01:09 Export PDF Favorites Scan
    47 pages Previous 1 2 3 ... 47 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南